RxDoctor Payments Data

Marc Hellerstein

Endocrinology, Diabetes & Metabolism · San Francisco, CANPI 1780884098

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $54,874 of the $56,364 with a category attached, or 97.4%. 4 manufacturers reported payments, led by Gilead at 34.1% of the total. Reporting peaked in 2021 at $17,320 and has fallen 54.9% since, to $7,813 in 2025. Among endocrinology, diabetes & metabolism clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,364in general payments, 2019–2025

Across 22 payments — averaging $2561.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$19K
  • Eli Lilly$14K
  • Pfizer$14K
  • AbbVie$9K
$1,181,056in research payments, 2019–2025

Across 13 payments — averaging $90,850 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$845K
  • Merck$186K
  • Pfizer$150K

What the payments were for

  • Consulting fees$54,87497%
  • Travel & lodging$1,2682%
  • Food & beverage$2220%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead3$19,220
Eli Lilly5$14,063
Pfizer4$13,800
AbbVie10$9,281

How this compares

$56,364 in reported general payments places this provider in the 90th percentile of 952 endocrinology, diabetes & metabolism providers in California.

See all endocrinology, diabetes & metabolism providers in California

Other endocrinology, diabetes & metabolism in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →